95 related articles for article (PubMed ID: 20301114)
21. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
Sun Q; Liu C; Zhong H; Zhong B; Xu H; Shen W; Wang D
Jpn J Clin Oncol; 2009 Apr; 39(4):237-43. PubMed ID: 19264768
[TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
Haag GM; Stocker G; Quidde J; Jaeger D; Lordick F
BMC Cancer; 2017 Jul; 17(1):509. PubMed ID: 28760152
[TBL] [Abstract][Full Text] [Related]
23. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.
Ter Veer E; van Kleef JJ; Sprangers MAG; Haj Mohammad N; van Oijen MGH; van Laarhoven HWM
Gastric Cancer; 2018 Mar; 21(2):183-195. PubMed ID: 29380191
[TBL] [Abstract][Full Text] [Related]
24. Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis.
van Kleef JJ; Ter Veer E; van den Boorn HG; Schokker S; Ngai LL; Prins MJ; Mohammad NH; van de Poll-Franse LV; Zwinderman AH; van Oijen MGH; Sprangers MAG; van Laarhoven HWM
J Natl Cancer Inst; 2020 Jan; 112(1):12-29. PubMed ID: 31251346
[TBL] [Abstract][Full Text] [Related]
25. Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy.
Pape M; Vissers PAJ; Slingerland M; Haj Mohammad N; van Rossum PSN; Verhoeven RHA; van Laarhoven HWM;
Support Care Cancer; 2023 Aug; 31(9):520. PubMed ID: 37578590
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapeutic and targeted strategies for locally advanced and metastatic esophageal cancer.
Forde PM; Kelly RJ
J Thorac Oncol; 2013 Jun; 8(6):673-84. PubMed ID: 23591158
[TBL] [Abstract][Full Text] [Related]
27. Metastatic gastric cancer treatment: Second line and beyond.
Ghosn M; Tabchi S; Kourie HR; Tehfe M
World J Gastroenterol; 2016 Mar; 22(11):3069-77. PubMed ID: 27003986
[TBL] [Abstract][Full Text] [Related]
28. Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors.
Uson Junior PLS; Santos VM; Bugano DDG; Victor EDS; Rother ET; Maluf FC
Sci Rep; 2019 Nov; 9(1):15806. PubMed ID: 31676841
[TBL] [Abstract][Full Text] [Related]
29. Quality of life in patients with advanced colorectal cancer: what has been learnt?
Conroy T; Bleiberg H; Glimelius B
Eur J Cancer; 2003 Feb; 39(3):287-94. PubMed ID: 12565979
[TBL] [Abstract][Full Text] [Related]
30. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review.
Kristensen A; Vagnildhaug OM; Grønberg BH; Kaasa S; Laird B; Solheim TS
Crit Rev Oncol Hematol; 2016 Mar; 99():286-98. PubMed ID: 26819138
[TBL] [Abstract][Full Text] [Related]
31. Health-Related Quality of Life in Locally Advanced Gastric Cancer: A Systematic Review.
van Amelsfoort RM; van der Sluis K; Schats W; Jansen EPM; van Sandick JW; Verheij M; Walraven I
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885043
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the health-related quality of life of esophageal cancer patients.
Chang D; Church J
Pract Radiat Oncol; 2014; 4(3):181-186. PubMed ID: 24766685
[TBL] [Abstract][Full Text] [Related]
33. Effects of nutritional and psychological status of the patients with advanced stomach cancer on physical performance status.
Tian J; Chen ZC; Hang LF
Support Care Cancer; 2009 Oct; 17(10):1263-8. PubMed ID: 19172303
[TBL] [Abstract][Full Text] [Related]
34. Impact of surgical treatment on quality of life of patients with gastrointestinal tumors.
Barbarisi A; Parisi V; Parmeggiani U; Cremona F; Delrio P
Ann Oncol; 2001; 12 Suppl 3():S27-30. PubMed ID: 11804380
[TBL] [Abstract][Full Text] [Related]
35. The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival.
Vissers PAJ; Luijten JCHBM; Lemmens VEPP; van Laarhoven HWM; Slingerland M; Wijnhoven BPL; Rosman C; Mook S; Heisterkamp J; Hendriksen EM; Gisbertz SS; Nieuwenhuijzen GAP; Verhoeven RHA
Eur J Surg Oncol; 2023 Oct; 49(10):107019. PubMed ID: 37659340
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in inoperable gastric cancer chemotherapy.
Kurihara M; Matsukawa M
Intern Med; 1995 Apr; 34(4):296-8. PubMed ID: 7606106
[No Abstract] [Full Text] [Related]
37. Nomograms for Predicting Risk and Survival of Esophageal Cancer Lung Metastases: a SEER Analysis.
He W; Yu Y; Yan Z; Luo N; Yang W; Li F; Jin H; Zhang Y; Ma X; Ma M
J Cancer; 2024; 15(11):3370-3380. PubMed ID: 38817873
[No Abstract] [Full Text] [Related]
38. The Oesophageal Cancer Multidisciplinary Team: Can Machine Learning Assist Decision-Making?
Thavanesan N; Vigneswaran G; Bodala I; Underwood TJ
J Gastrointest Surg; 2023 Apr; 27(4):807-822. PubMed ID: 36689150
[TBL] [Abstract][Full Text] [Related]
39. Current progress in the development of prophylactic and therapeutic vaccines.
Li T; Qian C; Gu Y; Zhang J; Li S; Xia N
Sci China Life Sci; 2023 Apr; 66(4):679-710. PubMed ID: 36469218
[TBL] [Abstract][Full Text] [Related]
40. SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
Kuijper SC; Pape M; Haj Mohammad N; van Voorthuizen T; Verhoeven RHA; van Laarhoven HWM
Int J Cancer; 2023 Mar; 152(6):1202-1209. PubMed ID: 36451334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
